TargetMol

Gefarnate

Product Code:
 
TAR-T7099
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7099-50mg50mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7099-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7099-100mg100mg£132.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7099-200mg200mg£162.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Gefarnate is a synthetic compound used for the treatment of gastric ulcers,and also used in the treatment of dry eye syndrome.
CAS:
51-77-4
Formula:
C27H44O2
Molecular Weight:
400.647
Purity:
0.971
SMILES:
CC(C)=CCCC(C)=CCCC(C)=CCCC(=O)OCC=C(/C)CCC=C(C)C

References

Du Y Q , Su T , Hao J Y , et al. Gastro-protecting effect of gefarnate on chronic erosive gastritis with dyspeptic symptoms[J]. Chinese Medical Journal, 2012, 125. Dota A , Takaoka-Shichijo Y , Nakamura M . Gefarnate stimulates mucin-like glycoprotein secretion in conjunctival tissue and ameliorates corneal epithelial damage in animal dry-eye models[J]. Clinical ophthalmology (Auckland, N.Z.), 2013, 7(default):211-217. Ohta Y , Kobayashi T , Imai Y , et al. Effect of Gefarnate on Acute Gastric Mucosal Lesion Progression in Rats Treated with Compound 48/80, a Mast Cell Degranulator, in Comparison with That of Teprenone[J]. Biological & Pharmaceutical Bulletin, 2005, 28(8):1424-1430.